Individualizing long-term treatment and care in active MS

Two
experts in MS explore the evolving practicalities of therapeutic sequencing
options in multiple sclerosis (MS). They discuss when to consider high-efficacy
disease-modifying therapies (DMTs), how to optimize a switch in DMT, and
practical considerations surrounding the use of DMTs in women of childbearing
age living with MS.

Click here to watch this recorded conversation

Click to Subscribe for the MS Beacon eNewsletter, resources and MS education